Efficacy and Safety of FIAsp in a Basal-bolus Regimen Versus Basal Insulin Therapy, Both in Combination With Metformin in Adult Subjects With Type 2 Diabetes
Public ClinicalTrials.gov record NCT01850615. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is conducted in Asia, Europe, South America, and the United States of America (USA). The aim of the trial is to investigate efficacy and safety of FIAsp in a basal-bolus regimen versus basal insulin therapy, both in combination with metformin in adult subjects with type 2 diabetes.
Study identification
- NCT ID
- NCT01850615
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 323 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 23, 2013 (Actual)
- Primary completion
- Nov 17, 2014 (Actual)
- Completion
- Nov 17, 2014 (Actual)
- Last update posted
- Jun 12, 2019
2013 – 2014
United States locations
- U.S. sites
- 32
- U.S. states
- 22
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Investigational Site | Birmingham | Alabama | 35211 | — |
| Novo Nordisk Investigational Site | Birmingham | Alabama | 35216 | — |
| Novo Nordisk Investigational Site | Peoria | Arizona | 85381 | — |
| Novo Nordisk Investigational Site | Little Rock | Arkansas | 72205 | — |
| Novo Nordisk Investigational Site | Santa Ana | California | 92705 | — |
| Novo Nordisk Investigational Site | Tarzana | California | 91356-3551 | — |
| Novo Nordisk Investigational Site | Colorado Springs | Colorado | 80907 | — |
| Novo Nordisk Investigational Site | Colorado Springs | Colorado | 80922 | — |
| Novo Nordisk Investigational Site | Clearwater | Florida | 33765 | — |
| Novo Nordisk Investigational Site | Pembroke Pines | Florida | 33028 | — |
| Novo Nordisk Investigational Site | Conyers | Georgia | 30094-5965 | — |
| Novo Nordisk Investigational Site | New Orleans | Louisiana | 70121 | — |
| Novo Nordisk Investigational Site | Rockville | Maryland | 20852 | — |
| Novo Nordisk Investigational Site | Boston | Massachusetts | 02118 | — |
| Novo Nordisk Investigational Site | Kalamazoo | Michigan | 49009 | — |
| Novo Nordisk Investigational Site | Omaha | Nebraska | 68144 | — |
| Novo Nordisk Investigational Site | Henderson | Nevada | 89052 | — |
| Novo Nordisk Investigational Site | Las Vegas | Nevada | 89120 | — |
| Novo Nordisk Investigational Site | Brooklyn | New York | 11229 | — |
| Novo Nordisk Investigational Site | Asheboro | North Carolina | 27203 | — |
| Novo Nordisk Investigational Site | Cincinnati | Ohio | 45242 | — |
| Novo Nordisk Investigational Site | Oklahoma City | Oklahoma | 73104 | — |
| Novo Nordisk Investigational Site | Downingtown | Pennsylvania | 19335-2620 | — |
| Novo Nordisk Investigational Site | Reading | Pennsylvania | 19609 | — |
| Novo Nordisk Investigational Site | Greenville | South Carolina | 29605-4254 | — |
| Novo Nordisk Investigational Site | Greer | South Carolina | 29651 | — |
| Novo Nordisk Investigational Site | Memphis | Tennessee | 38119-3821 | — |
| Novo Nordisk Investigational Site | Fort Worth | Texas | 76132 | — |
| Novo Nordisk Investigational Site | Houston | Texas | 77025-1669 | — |
| Novo Nordisk Investigational Site | San Antonio | Texas | 78229 | — |
| Novo Nordisk Investigational Site | Sugar Land | Texas | 77478 | — |
| Novo Nordisk Investigational Site | Ogden | Utah | 84405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 26 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01850615, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 12, 2019 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01850615 live on ClinicalTrials.gov.